Definition of Mental Disorder
(MHA s.1(1)(g))
A substantial disorder of thought, mood, perception,
orientation, or memory that grossly impairs: judgment,
behavior, capacity to recognize reality or ability to meet
the ordinary demands of life, but does not include a
disorder in which the resulting impairment is persistent
and is caused solely by an acquired or congenital
irreversible brain injury.
A. Criteria for CTO
(MHA s.9.1(1))
Two QHPs - one MUST be a psychiatrist - may, issue a
CTO with respect to a person if they meet a) through f):
a. person is suffering from a mental disorder, and
b. one or more of the following apply:
i. within the immediate preceding 3-year period the
person has on two or more occasions, or for a
total of at least 30 days,
A. been a formal patient in a facility or
B. been in an approved hospital or been lawfully
detained in a custodial institution where there
is evidence satisfactory to the two QHP that,
while there, the person would have met the
criteria (for a formal patient) at that time or
those times, or
C. both A. and B. above
ii. the person has within the immediately preceding
3-year period been subject to a CTO
iii.
in the opinion of the two QHPs, the person has,
while living in the community, exhibited a pattern
of recurrent or repetitive behavior that indicates
that the person is likely to cause harm to others or
to suffer negative effects, including substantial
mental or physical deterioration or serious physical
impairment, as a result of or related to the mental
disorder, if the person does not receive continuing
treatment or care while living in the community, or
iv. a review panel has ordered a board to issue the
CTO under MHA s.41,
c.
Two QHPs, after separate examinations of the person
within the immediately preceding 72 hours, are both of
the opinion that the person is within a reasonable time,
likely to cause harm to others or to suffer negative
effects, including substantial mental or physical
deterioration or serious physical impairment, as a
result of or rel ated to the mental disorder, if the person
does not receive continuing treatment or care while
living in the community, and
d. treatment or care the person requires exists in the
community, is available to the person, and will be
provided to the person,
and
e.
in the opinion of each QHP, the person is able to
comply with the treatment or care requirements set out
in the CTO, and
f.
either,
i. consent to the issuing of the CTO has been
obtained,
A. from the person, if they are competent, or
B. in accordance with section 28(1), if they are
not competent
or
ii. consent to the issuing of the CTO has NOT been
obtained, but in the opinion of the issuing QHPs,
A. person has, while living in the community,
exhibited a history of not obtaining or
continuing with treatment or care that is
necessary to prevent the likelihood of
negative effects to the person, including
substantial mental or physical deterioration
or serious physical impairment, as a result of
or related to the mental disorder, or of harm
to others, and
B. a CTO is reasonable and would be less
restrictive than retaining the person as a
formal patient.
Community Treatment Order Key Points
Mental Health Act (MHA) of Alberta
Refer to the Mental Health Act and its regulations for more comprehensive information. Reliance on this document is solely at t he user’s risk; AHS is not responsible for errors or omissions and will not be
responsible or liable for any claims arising based on the use (or misuse) of information contained herein. This material may be reproduced or copied in full for educational and program development purposes
or not-for-profit or non-commercial activities without permission. © 2022 Alberta Health Services
All Mental Health Act forms can be found on the website: https://www.albertahealthservices.ca/info/Page1256.aspx
For additional information on the Mental Health Act please visit https://www.albertahealthservices.ca/info/mha.aspx
For any enquiries about these materials please email: MHAandCTO.Enquiries@ahs.ca
B. Issuing/Renewing a CTO
(MHA s.9.1, s. 9.2, s. 9.3; CTO Reg. s. 1-2)
•
Renewal criteria are the same as issuance criteria
(see A) except the allowable time between the first
examination and completion of all parts of the
prescribed form is 7 days instead of 72 hours.
•
“Issuing qualified health professional” means the QHP
who last issued, renewed, or amended a CTO.
•
Examinations for the purposes of issuance or renewal
may be conducted remotely using any means
considered appropriate by the examining QHP,
including, but not limited to, video conference.
•
A CTO is valid for 6 months and can be renewed
anytime before its expiry.
•
Formal patient admission or renewal certificates are
automatically cancelled upon the issuance of a CTO.
C. Mental Competency
(MHA s.26, s. 28)
Competency means that a person is able to understand
the subject matter relating to, and the consequences of,
making treatment decisions or giving consent and the
consequences of not doing so.
When a physician determines a person subject to a CTO
is incompetent to make treatment decisions, these
decisions may be made by the:
a. agent of the person (under an enacted personal
directive)
b. guardian of the person on a CTO
c. nearest relative as defined in section 1(i), or
d. Public Guardian (last resort)
The nearest relative option is not utilized when an agent
or guardian is in place. The SDM shall make the
treatment decisions in the best interest of the person.
D. Form Requirements
(MHA s.9.1(2) CTO Reg. s.4)
Must be written on the correct and most current version of
the form (Form 19 or 20)
•
Identify and be signed by the issuing QHP, a second
examining QHP, the supervising QHP (if different from
issuing QHP) and all treatment providers
•
Contain the dates and location (city/town & facility) of
the examinations, the rationale/ facts from which the
examining QHPs formed their opinions and the
treatment and care to be provided.
if the treatment and care plan requires services
provided by the regional health authority (i.e., AHS), a
person authorized to approve the service must sign the
CTO (e.g., Program Manager).
E. Notification of CTO Issuance,
Amendment and Renewal
(MHA s.14(1.1), s. 14(2), s. 14(4) CTO Reg. s.7, s.8)
Who to notify:
•
Person subject to CTO
•
SDM under MHA s. 28 (if any)(see C above)
•
Issuing QHP
•
Supervising QHP
•
ALL treatment providers named in the CTO
•
Nearest relative (unless patient objects on reasonable
grounds)
•
One person designated by person subject to CTO (if
any)
What to include in the notification:
•
Copies of issued, amended or renewed CTO
•
Written statement (of Forms 19, 20 & 21) with the
following requirements in simple language, using an
interpreter if required :
reason & authority for issuance, amendment or
renewal of CTO
function & contact information of the review panels
right of the person subject to the CTO to apply for a
review panel hearing to cancel a CTO
only for person subject to CTO or their SDM
F. Amendment Considerations
(MHA s. 9.4)
•
A CTO can be amended by a QHP.
•
An amendment must be on Form 21 with copy of most
recent CTO (Form 19 or 20) attached.
•
If medication is stated by class (e.g.,
“antidepressant
”
in Part III of a Form 19 or 20), adjustments within that
class of medication do not require an amendment.
G. Cancellation/Expiry
(MHA s.9.2, s.9.5; CTO Reg. 8(2))
•
A CTO can only be cancelled by a psychiatrist, revi ew
panel decision, or Court of King
’s Bench.
•
If the supervising QHP is not a psychiatrist,
consultation with a psychiatrist when CTO criteria no
longer met is required to complete Form 22.
•
Supervising QHP to issue notice of the expiry of a
CTO on Form 22
.
•
All individuals notified of the issuance, amendment or
renewal of a CTO (see E), as well as the physician or
nurse practitioner who treats the person in their
ordinary day-to-day health care needs (if known)
requires notification of expiry or cancellation, along
with any recommendations for treatment.
H. Review Panel
(MHA s.34-43; CTO Reg. 9(1))
•
The person subject to a CTO or anyone on their
behalf, may apply for a review panel hearing via Form
12 to cancel a CTO
.
•
Review panel is composed of a chair or vice-chair
(must be lawyers), a psychiatrist & a member of the
public.
•
Review panel to be held within 21 days of the chair
receiving the application, and their decision to be
issued within 48 hours of the hearing.
•
The person subject to a CTO has the right to legal
representation at all review panel hearings.
•
Issuing QHP to send copy of renewal forms to review
panel for deemed applications.
•
Any decision or order of the review panel may be
appealed to the Court of
King’s Bench.
I. Non CTO Clinical Considerations
•
When a person does not meet the criteria for a CTO,
the CTO has expired or has been cancelled, care
providers should consider:
need for hospital admission either as a formal
patient (see MHA s.2 for admission criteria) or as
a voluntary patient.
any
treatment recommendations the person may
be willing to accept voluntarily
.
Additional Information
•
Informed consent to treatment is a separate process
from consent to CTO.
•
Treatment providers are responsible to obtain and
appropriately document informed consent for the
treatment they provide.
•
In addition to the prescribed MHA forms referenced, all
providers are expected to follow professional standards
and organizational guidelines for documentation.